ZLDPF

Zealand Pharma A/S/ADR

Healthcare · Biotechnology

$67.43 sample

-0.17 (-0.25%) 1D

Market cap

$353.0B

Price as of

2026-10-03

Latest filing

8-K · 2026-08-19

Alerts

8

Price$67.43 +26.08% 3M daily closessample

67.6052.49

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 25INSInsider sell: EVP, Operations
Sep 17INSInsider buy: 10% owner
Sep 10INSInsider sell: Chief Financial Officer
Sep 04INSInsider buy: General Counsel
Aug 28INSInsider buy: EVP, Operations
Aug 24INSInsider sell: General Counsel
Aug 19SECForm 144 filed
Aug 11INSInsider sell: Chief Executive Officer

Sign up to see the real ZLDPF record →

Company facts

SEC EDGAR registration

Name: Zealand Pharma A/S/ADR
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +34sample, -100 to +100
Reporting currency: USD

Who is positioning in ZLDPF

sample

Insiders: 23 insider transactions over 90 days, net selling, $333.3M
Congress: 2 members traded over 90 days
Institutions · 13F: 16 funds hold $7.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$10.2B +15.8% y/y

Q4 2024Q3 2026

Inventory$5.9B +11.5% y/y

Q4 2024Q3 2026

Accounts receivable$4.7B +22.9% y/y

Q4 2024Q3 2026

Total debt$12.1B +17.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $220.2B -6.0% 3M
Sample peer B: $261.0B +2.4% 3M
Sample peer C: $292.9B -5.7% 3M
Sample peer D: $190.3B +11.1% 3M
Sample peer E: $333.4B +7.1% 3M